GlaxoSmithKline news from FierceHealthcare
NewsTexas A&M joins chase for $1.2B biosecurity program
Texas A&M has created a team of scientists, researchers and clinicians to pursue a $1.2 billion HHS "biosecurity" contract. Winning the bid would mean creating a biosecurity center to develop Read more...
Pharmacists increasingly helping patients to stay on track
Roughly $300 billion is spent each year on emergency and hospital care for patients who don't take their medications as prescribed. To help keep those patients on the right track, more pharmacies Read more...
Medical educators in Pennsylvania received at least $10 million from drug companies in 2009
Conflict-of-interest allegations aside, several Pittsburgh-area doctors and nurse educators are insisting that their work is not compromised despite data showing they were paid roughly $3.5 million Read more...
Glaxo stops funding commercial CME; Merck funding $150M non-profit vaccine developer;
> In another sign that drugmakers want to reduce their exposure to payola allegations, GlaxoSmithKline has announced that it will stop funding commercial continuing medical education programs. Read more...
Case study: Miami drug reps not registering as lobbyists
Right now, sentiment is high on Capitol Hill to expose the money flowing to doctors from pharmaceutical and medical device companies. A look at what's happening in some markets right now, however, Read more...
Pfizer will disclose payments to health professionals
Pfizer has announced that it plans to make data on payments to healthcare professionals publicly available starting in early 2010, including not only physicians, but also researchers and research Read more...
Emory punishes psychiatrist Nemeroff for drug company ties
Internationally known psychiatrist Dr. Charles Nemeroff is facing serious consequences for taking payments from pharmaceutical companies. Emory University has permanently stripped him of his Read more...
More objections to Avandia suppressed by Glaxo
We haven't heard anything for a while about Avandia, GlaxoSmithKline's diabetes drug that has been linked to a higher risk of heart attacks, but that doesn't mean no one has been paying attention. Read more...
Emory psychiatrist accused of not reporting drug company income
A high-profile Emory University psychiatrist has been accused of failing to report one-third of the $2.8 million in consulting fees he received from companies whose drugs he was evaluating, according Read more...
Glaxo to report grants to U.S. healthcare groups
Bowing to emerging trends favoring such disclosures, drugmaker GlaxoSmithKline has announced plans to publicly report the grants it provides to U.S. healthcare organizations. The report, which will Read more...
| Press ReleasesStrategic changes by big pharma accounted for 60% of partnership deal terminations between January 2010 and June 2011: com40% of pharmaceutical partnership deals terminated between January 2010 and June 2011 were valued at $400m-$600mStrategic changes are cited as the most common reason behind pharmaceutical deal Read more >> BARDA Partners to Develop New Class of AntibioticContract supports new antibiotic against bioterrorism threats, Gram-negative infections WASHINGTON--(BUSINESS WIRE)-- The federal government today issued a contract for advanced research and Read more >> Dr. Tadataka Yamada Joins Frazier HealthcareSEATTLE--(BUSINESS WIRE)-- Frazier Healthcare, a leading provider of growth equity and venture capital to high growth and emerging healthcare companies, announced today that Dr. Tadataka (Tachi) Read more >> DecisionView to Create Clinical Trial Enrollment BenchmarksPatient Enrollment Data Aggregated from Leading Pharmaceutical Companies Including GlaxoSmithKline and Roche Will Be Made Available via DecisionView's StudyOptimizer™ Patient Enrollment Optimization Read more >> DecisionView Secures Leadership Position in the Patient Enrollment Optimization Market With 7 of the Top 10 Global PharmaceuticaWith Bookings and Clinical Trials Under Contract More Than Doubling, The Industry Has Validated DecisionView's Approach To Optimizing Patient EnrollmentSAN FRANCISCO, Feb. 17, 2011 /PRNewswire/ -- Read more >> |
